JP2002060340A5 - - Google Patents

Download PDF

Info

Publication number
JP2002060340A5
JP2002060340A5 JP2000248021A JP2000248021A JP2002060340A5 JP 2002060340 A5 JP2002060340 A5 JP 2002060340A5 JP 2000248021 A JP2000248021 A JP 2000248021A JP 2000248021 A JP2000248021 A JP 2000248021A JP 2002060340 A5 JP2002060340 A5 JP 2002060340A5
Authority
JP
Japan
Prior art keywords
neurite outgrowth
polyalkoxyflavonoid
represented
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000248021A
Other languages
English (en)
Japanese (ja)
Other versions
JP4633897B2 (ja
JP2002060340A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000248021A priority Critical patent/JP4633897B2/ja
Priority claimed from JP2000248021A external-priority patent/JP4633897B2/ja
Priority to US09/927,038 priority patent/US20020040052A1/en
Publication of JP2002060340A publication Critical patent/JP2002060340A/ja
Publication of JP2002060340A5 publication Critical patent/JP2002060340A5/ja
Application granted granted Critical
Publication of JP4633897B2 publication Critical patent/JP4633897B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000248021A 2000-08-17 2000-08-17 神経突起伸長剤 Expired - Lifetime JP4633897B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000248021A JP4633897B2 (ja) 2000-08-17 2000-08-17 神経突起伸長剤
US09/927,038 US20020040052A1 (en) 2000-08-17 2001-08-09 Method for neurite outgrowth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000248021A JP4633897B2 (ja) 2000-08-17 2000-08-17 神経突起伸長剤

Publications (3)

Publication Number Publication Date
JP2002060340A JP2002060340A (ja) 2002-02-26
JP2002060340A5 true JP2002060340A5 (https=) 2007-07-26
JP4633897B2 JP4633897B2 (ja) 2011-02-16

Family

ID=18738008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000248021A Expired - Lifetime JP4633897B2 (ja) 2000-08-17 2000-08-17 神経突起伸長剤

Country Status (2)

Country Link
US (1) US20020040052A1 (https=)
JP (1) JP4633897B2 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7146209B2 (en) * 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
WO2003090599A2 (en) * 2002-04-25 2003-11-06 Brainsgate Ltd. Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
WO2004043218A2 (en) * 2002-11-14 2004-05-27 Brainsgate Ltd. Surgical tools and techniques for stimulation
US7684859B2 (en) * 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
JP2004284961A (ja) * 2003-03-19 2004-10-14 Okinawa Pref Gov 抗腫瘍成分をサルカケミカンから抽出した製剤、食品または食品添加物
JP4820170B2 (ja) * 2003-12-05 2011-11-24 大日本住友製薬株式会社 虚血性神経障害治療又は予防剤
US8010189B2 (en) * 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
JP4505555B2 (ja) * 2004-03-02 2010-07-21 康 大泉 神経変性疾患治療剤
US7887851B2 (en) * 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
US20090299418A1 (en) * 2004-08-23 2009-12-03 Brainsgate Ltd. Concurrent bilateral spg modulation
WO2006049234A1 (ja) * 2004-11-08 2006-05-11 Arkray, Inc. ペルオキシソーム増殖剤応答性受容体(ppar)活性化剤、ならびにそれを用いた医薬、サプリメント、機能性食品および食品添加物
JP2007061028A (ja) * 2005-09-01 2007-03-15 Yasushi Oizumi 学習記憶障害を改善する機能性食品
JP5563181B2 (ja) * 2005-09-01 2014-07-30 ポッカサッポロフード&ビバレッジ株式会社 インスリン抵抗性改善剤及び血糖値低下剤
JP2007302572A (ja) * 2006-05-09 2007-11-22 Pokka Corp 脳機能改善剤及びそれを含有する脳機能改善組成物
JP2007332118A (ja) * 2006-06-19 2007-12-27 Minamide Shoji Kk 神経保護剤
US20090210026A1 (en) * 2006-08-17 2009-08-20 Brainsgate Ltd. Spg stimulation for enhancing neurogenesis and brain metabolism
US20080227829A1 (en) * 2007-02-14 2008-09-18 Hammerstone John F Neurogenic compounds
JP4921297B2 (ja) * 2007-09-18 2012-04-25 株式会社サウスプロダクト ポリメトキシフラボノイドの抽出方法
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
EP2112145A1 (en) * 2008-04-24 2009-10-28 AxoGlia Therapeutics S.A. Chromenone derivatives useful for the treatment of neurodegenerative diseases
CN101801398A (zh) * 2008-06-17 2010-08-11 日本蜂王浆株式会社 认知障碍改善剂
KR20120023787A (ko) * 2009-05-22 2012-03-13 가부시키가이샤 에리나 대사증후군의 예방제 및/또는 치료제
JP5667358B2 (ja) 2009-06-03 2015-02-12 富士産業株式会社 柑橘類果皮の麹菌発酵組成物
JP5663576B2 (ja) 2010-07-06 2015-02-04 秀則 上西 神経突起伸長剤
JP6114488B2 (ja) * 2011-05-09 2017-04-12 共栄化学工業株式会社 線維芽細胞増殖因子産生促進剤、血管内皮細胞増殖因子産生促進剤、及び毛髪化粧料
US9527860B2 (en) 2011-06-17 2016-12-27 Ludwig Aigner Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders
JP5945861B2 (ja) * 2011-09-29 2016-07-05 学校法人松山大学 医薬組成物及びその製造方法
CA2854281C (en) * 2011-12-26 2018-12-11 Morinaga Milk Industry Co., Ltd. A muscle atrophy inhibitor
KR101747125B1 (ko) * 2012-10-12 2017-06-14 고쿠리츠다이가쿠호진 류큐다이가쿠 감귤류 유래의 노비레틴 및 탄게레틴 함유물의 제조 방법 및 그 방법으로 얻은 노비레틴 및 탄게레틴 함유물
EP2939672B1 (en) * 2012-12-26 2019-10-30 Morinaga Milk Industry Co., Ltd. Igf-1 production promoter
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
JP6797408B2 (ja) 2014-11-06 2020-12-09 国立大学法人 長崎大学 新規アルツハイマー病治療薬
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
JP6472411B2 (ja) * 2016-06-01 2019-02-20 株式会社三協ホールディングス 医薬組成物および食品
FR3053250B1 (fr) 2016-07-01 2020-11-27 Laboratoires M&L Utilisation d'une huile essentielle d'immortelle pour augmenter ou restaurer la perception tactile cutanee
US11160782B2 (en) 2016-08-04 2021-11-02 Kao Corporation Method for producing nobiletin-containing solid dispersion
US11236060B2 (en) 2018-03-22 2022-02-01 Kao Corporation Method for producing solid dispersion containing nobiletin
CN112402409A (zh) * 2020-12-11 2021-02-26 江汉大学 橘皮素在制备抑制β分泌酶活性药物中的应用
FR3130556B1 (fr) 2021-12-16 2026-02-13 Oreal Utilisation d’acide salicylique et/ou de ses dérivés et/ou de leurs sels, pour augmenter ou restaurer la perception tactile cutanée

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0578384A (ja) * 1991-03-27 1993-03-30 Taisho Pharmaceut Co Ltd フラボノール誘導体
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases

Similar Documents

Publication Publication Date Title
JP2002060340A5 (https=)
JP2002541233A5 (https=)
JP2003531118A5 (https=)
JP2007517043A5 (https=)
JP2003523927A5 (https=)
JP2002332234A5 (https=)
JP2007511546A5 (https=)
JP2005508905A5 (https=)
JP2007500753A5 (https=)
JP2005518413A5 (https=)
JP2007510619A5 (https=)
CA2413163A1 (en) 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
JP2005237328A5 (https=)
JP2003502367A5 (https=)
DE60203197D1 (de) 4-(oxadiazol-3-yl)-1,4-diazabizyklo[3.2.2]-nonanderivate, ihre herstellung und therapeutische verwendung
JP2002535387A5 (https=)
JP2002522501A5 (https=)
JP2002506864A5 (https=)
ITTO20020043A0 (it) Struttura di filtro dell'aria per veicolo.
JP2003514090A5 (https=)
JP2002525033A5 (https=)
JP2006510659A5 (https=)
NO20041675L (no) Ny bakteriell fjaerfesykdom
JP2002277470A5 (https=)
JP2003514806A5 (https=)